Gene · 55768
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impacts of N-glycanase1 (NGLY1) Down Regulation on the Function of Mitochondria. | J Cell Biochem | 2026 | 42634536 | PubTator, text mining | PubMed |
| Epigenomewide Association Study of Monozygotic Twins Reveals That Serum Uric Acid Influences DNA Methylation. | Twin Res Hum Genet | 2026 | 42165100 | PubTator, text mining | PubMed |
| Discovering the Hidden Power of NGLY1: Orchestrating Immune Cell Functions and Autoimmune Diseases. | Front Biosci (Landmark Ed) | 2026 | 42052850 | PubTator, text mining | PubMed |
| VE-cadherin interaction proteomics identifies ARVCF as stabilizer of endothelial adherens junctions. | iScience | 2026 | 42006337 | PubTator, text mining | PubMed |
| Cytosolic Peptide: N-Glycanase (NGLY1)-from Basic Biology to Genetic Disorder, NGLY1 Deficiency. | Adv Exp Med Biol | 2026 | 41917400 | PubTator, text mining | PubMed |
| Nrf3: an emerging player in cancer, inflammation, and cellular homeostasis. | Mol Biol Rep | 2026 | 41838283 | PubTator, text mining | PubMed |
| Directed evolution of Clec12a-binding peptides using mammalian-expressed recombinant protein. | Biochem Biophys Rep | 2026 | 41799695 | PubTator, text mining | PubMed |
| Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome. | J Hum Immun | 2026 | 41783139 | PubTator, text mining | PubMed |
| The Role of Glycan Structures in Modulating GM-CSF Bioactivity: Insights from Glycoengineering. | bioRxiv | 2026 | 41756846 | PubTator, text mining | PubMed |
| Myoclonus in Pediatric Metabolic Diseases: Clinical Spectrum, Mechanisms, and Treatable Causes-A Systematic Review. | Metabolites | 2026 | 41745581 | PubTator, text mining | PubMed |
| Targeting pyroptosis in periodontitis: mechanisms and therapeutic strategies. | Front Immunol | 2026 | 41727505 | PubTator, text mining | PubMed |
| Generation and characterization of human iPSC-derived NPC1 I1061T/I10161T i3Neurons as a model for NPC1 disease. | bioRxiv | 2026 | 41726996 | PubTator, text mining | PubMed |
| Simultaneous detection of PNGase and ENGase activities in tissue lysate or cytosol using a simply designed high-mannose-type glycopeptide probe containing an Asn-leu-leu sequence. | Bioorg Med Chem Lett | 2026 | 41687896 | PubTator, text mining | PubMed |
| Biochemical analysis of a TrkB receptor mutation that causes a developmental epileptic encephalopathy. | J Biol Chem | 2026 | 41525844 | PubTator, text mining | PubMed |
| NFE2L1/Nrf1 forms a coactivator complex post-peptide:N-glycanase-mediated sequence editing and mitigates proteasome dysfunction. | Proc Natl Acad Sci U S A | 2026 | 41468431 | Swiss-Prot, curated | PubMed |
| GlycoRNA research: from unknown unknowns to known unknowns. | Protein Cell | 2026 | 41264770 | PubTator, text mining | PubMed |
| Erratum: [Erratum] Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease. | Eur J Case Rep Intern Med | 2025 | 41229653 | PubTator, text mining | PubMed |
| Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease. | Eur J Case Rep Intern Med | 2025 | 41229635 | PubTator, text mining | PubMed |
| Simulated Solute Tempering 2: An Efficient and Practical Approach to Protein Conformational Sampling and Binding Events. | J Chem Theory Comput | 2025 | 41139839 | PubTator, text mining | PubMed |
| Modular generation of multispecific antibodies using protein trans-splicing. | MAbs | 2025 | 41104655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55768/papers